Lv4
480 积分 2026-05-28 加入
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
30天前
已完结
Head and Neck Cancer
30天前
已完结
Partial irradiation of the parotid gland
30天前
已完结
The prevention and treatment of radiotherapy-induced xerostomia
30天前
已完结
Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study
30天前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
30天前
已完结
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up
30天前
已完结
Reduction of Bone Fracture After Radiation Therapy in Lower Extremity Soft Tissue Sarcoma After Implementing Bone Avoidance Objectives for Radiation Therapy Planning
2个月前
已完结
The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: a prospective, real-word study with a large population
2个月前
已完结
Individualized risk-adapted cranial border for nodal clinical target volume in nasopharyngeal carcinoma: challenging the universal skull base rule
3个月前
已完结
皖公网安备34019202002308
